CFO and Principal Accounting OfficerMr. Jeffrey S. Farrow is Chief Financial Officer Principal Financial and Accounting Officer of ZS Pharma Inc. Mr. Farrow previously served as the Chief Financial Officer of Hyperion Therapeutics Inc. a commercial pharmaceutical company from July 2010 until May 2015. In addition Mr. Farrow served as Hyperions Secretary from May 2011 to August 2013 and Vice President Finance from February 2010 to June 2010. From May 2008 to December 2009 Mr. Farrow was Vice President Finance at Evotec AG a drug discovery and development company where Mr. Farrow was responsible for Evotecs corporate treasury function and compliance with the Sarbanes Oxley Act as well as overseeing the finance and general administrative functions of the companys Renovis subsidiary. From January 2004 to May 2008 Mr. Farrow held various positions with the most recent being Vice President Finance and Chief Accounting Officer at Renovis Inc. a drug discovery and development company which was acquired by Evotec AG in May 2008. Previously Mr. Farrow held various positions over his seven years in the audit practice of KPMG LLP and was most recently a Senior Manager
Age: 52 CFO Since 2015Farrow holds a B.A. in Business Administration with a concentration in Corporationrationrationrate Finance from California State University at Fullerton.